VEA
RXDX

Virtus ETF Advisers’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Virtus ETF Advisers’s Portfolio RXDX Stock Details RXDX Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$100K Sell
2022
Q4 		$142K Sell
2022
Q3 		$247K Buy
2022
Q2 		$117K Sell
2022
Q1 		$185K Sell
2021
Q4 		$204K Sell
2021
Q3 		$214K Sell
2021
Q2 		$234K Buy